Skip to main content
. 2014 Mar;21(3):302–311. doi: 10.1128/CVI.00617-13

FIG 8.

FIG 8

Solicited local and general symptoms during the 7-day postvaccination period following administration of a booster dose of the F4/AS01B investigational vaccine (pooled total vaccinated cohort for 10-μg-primed participants). Error bars represent 95% confidence intervals.